111 related articles for article (PubMed ID: 38008234)
1. Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil.
Sallam NG; Boraie NA; Sheta E; El-Habashy SE
Int J Pharm; 2024 Jan; 649():123637. PubMed ID: 38008234
[TBL] [Abstract][Full Text] [Related]
2. Surface modified genistein phytosome for breast cancer treatment: In-vitro appraisal, pharmacokinetics, and in-vivo antitumor efficacy.
Komeil IA; Abdallah OY; El-Refaie WM
Eur J Pharm Sci; 2022 Dec; 179():106297. PubMed ID: 36156294
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
Lu Z; Su J; Li Z; Zhan Y; Ye D
Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
[TBL] [Abstract][Full Text] [Related]
4. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model.
Ni X; Suhail MM; Yang Q; Cao A; Fung KM; Postier RG; Woolley C; Young G; Zhang J; Lin HK
BMC Complement Altern Med; 2012 Dec; 12():253. PubMed ID: 23237355
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells.
Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK
Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757
[TBL] [Abstract][Full Text] [Related]
6. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.
Shen H; He D; Wang S; Ding P; Wang J; Ju J
Drug Dev Ind Pharm; 2018 Sep; 44(9):1536-1542. PubMed ID: 29848136
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels.
Comert Onder F; Sagbas Suner S; Sahiner N; Ay M; Ozpolat B
Pharm Res; 2020 Mar; 37(3):63. PubMed ID: 32133571
[TBL] [Abstract][Full Text] [Related]
10. Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles.
Zhang T; Wang H; Ye Y; Zhang X; Wu B
Int J Nanomedicine; 2015; 10():6175-84. PubMed ID: 26491290
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells.
Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK
Biomacromolecules; 2015 Sep; 16(9):3042-53. PubMed ID: 26302089
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Etman SM; Abdallah OY; Mehanna RA; Elnaggar YSR
Int J Pharm; 2020 Mar; 578():119097. PubMed ID: 32032904
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy.
Aly S; El-Kamel AH; Sheta E; El-Habashy SE
Int J Pharm; 2023 Jul; 642():123163. PubMed ID: 37353100
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
[No Abstract] [Full Text] [Related]
16. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
[TBL] [Abstract][Full Text] [Related]
18. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterisation of chitosan-encapsulated genistein: its anti-proliferative and anti-angiogenic activities.
Rahmani F; Karimi E; Oskoueian E
J Microencapsul; 2020 Jun; 37(4):305-313. PubMed ID: 32148140
[No Abstract] [Full Text] [Related]
20. The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.
Nozawa F; Itami A; Saruc M; Kim M; Standop J; Picha KS; Cowan KH; Pour PM
Pancreas; 2004 Jul; 29(1):45-52. PubMed ID: 15211111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
